Virtu KCG Holdings’s Histogen Inc. Common Stock HSTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-752
Closed -$792K 3945
2016
Q4
$792K Buy
752
+413
+122% +$187K 0.02% 983
2016
Q3
$135K Buy
+339
New +$138K ﹤0.01% 2541
2016
Q2
Sell
-174
Closed -$74K 3457
2016
Q1
$74K Buy
+174
New +$67.2K ﹤0.01% 2385
2015
Q3
Sell
-183
Closed -$188K 3969
2015
Q2
$188K Buy
+183
New +$214K ﹤0.01% 2633
2015
Q1
Sell
-116
Closed -$163K 4071
2014
Q4
$163K Buy
116
+34
+41% +$49.1K ﹤0.01% 3006
2014
Q3
$99K Buy
+82
New +$118K ﹤0.01% 3189
2014
Q2
Sell
-53
Closed -$86K 4172
2014
Q1
$86K Buy
+53
New +$111K ﹤0.01% 3241

Other funds holding HSTO

Virtu KCG Holdings's HSTO Position: Q1 2017 in Review

Virtu KCG Holdings sold out of Histogen Inc. Common Stock (HSTO) in Q1 2017, closing a stake of 752 shares — an estimated $792K sold.

Virtu KCG Holdings first reported a position in HSTO in Q1 2014 and held it in 7 quarters. The position peaked at $792K in Q4 2016. 43 funds tracked by Wall St. Rank hold HSTO as of Q1 2017.

  • Virtu KCG Holdings reported no remaining Histogen Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 752 Histogen Inc. Common Stock shares in Q1 2017, an estimated $792K.
  • Virtu KCG Holdings first reported a position in Histogen Inc. Common Stock in Q1 2014 and held it in 7 quarters.
  • Virtu KCG Holdings's Histogen Inc. Common Stock position peaked at $792K in Q4 2016.
  • 43 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q1 2017.

Based on Virtu KCG Holdings's 13F filing for Q1 2017, filed 12 May 2017.